Amber Moore
Family · Sparta, TNNPI 1629662093
Payments from drug & device makers
Across 93 payments — averaging $18.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$427
- AbbVie$181
- AstraZeneca$167
- Merck$153
- Amgen$124
- Exact Sciences$111
- plus $577 from 16 others
What the payments were for
- Food & beverage$1,740100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 20 | $427 |
| AbbVie | 9 | $181 |
| AstraZeneca | 9 | $167 |
| Merck | 10 | $153 |
| Amgen | 8 | $124 |
| Exact Sciences | 7 | $111 |
| Lilly USA, LLC | 6 | $97 |
| Phathom Pharmaceuticals, Inc. | 4 | $86 |
| Novartis | 3 | $56 |
| Alkermes, Inc. | 3 | $53 |
| GSK | 3 | $53 |
| Inspire Medical Systems, Inc. | 1 | $41 |
| Otsuka America Pharmaceutical, Inc. | 1 | $25 |
| Lundbeck LLC | 1 | $23 |
| Corcept Therapeutics | 1 | $21 |
| Edwards Lifesciences | 1 | $21 |
| Tempus AI, Inc | 1 | $20 |
| Insulet Corporation | 1 | $19 |
| Axsome Therapeutics, Inc. | 1 | $17 |
| Nevro Corp. | 1 | $16 |
| Dexcom, Inc. | 1 | $16 |
| Neurocrine Biosciences, Inc. | 1 | $13 |
How this compares
$1,740 in reported general payments places this provider in the 75th percentile of 6,706 family providers in Tennessee.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 29 | $41,306 |
| OzempicSemaglutide | 25 | $35,303 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 22 | $33,097 |
| TrulicityDulaglutide | 20 | $31,798 |
| VraylarCariprazine Hcl | 14 | $18,337 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 11 | $3,783 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 70 | $2,766 |
| Omeprazole | 113 | $1,982 |
| Rosuvastatin Calcium | 102 | $1,576 |
| Atorvastatin Calcium | 124 | $1,365 |
| Diclofenac Sodium | 53 | $1,323 |
| Levothyroxine Sodium | 172 | $1,322 |
| Esomeprazole Magnesium | 22 | $1,244 |
| Duloxetine Hcl | 43 | $1,225 |
| Losartan Potassium | 111 | $1,211 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $427 | $35,30325 claims |
| GSKTrelegy Ellipta | $53 | $33,09722 claims |
| Lilly USA, LLCTrulicity | $97 | $31,79820 claims |
| AbbVieVraylar | $181 | $18,33714 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 6,706 family providers in Tennessee.
Other family in Sparta
- Stacy BrownMt Juliet$719K
- Dana WebberKnoxville$499K
- Brandy BiedermanHixson$448K
- Cynthia MillerMurfreesboro$384K
- Tamera ThoenerNashville$254K
- April SwonerHermitage$246K
- Jennifer WilliamsNashville$213K
- Chantil JeffreysGermantown$195K
- Laura PorchCordova$148K
- Lori LankfordNashville$148K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.